InvestorsHub on MSN
HeartBeam receives FDA breakthrough device designation for heart attack assessment
The designation gives HeartBeam prioritized FDA interaction as it prepares a pivotal study of its 3D ECG technology for ...
The FDA's Breakthrough Device Program is intended to speed the development and review of technologies that may provide more effective diagnosis or treatment of life-threatening conditions. The ...
SANTA CLARA, Calif., December 10, 2025--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, ...
Southlake, Texas, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) ("HeartSciences" or the "Company"), a medical technology company focused on ...
Researchers at Mount Sinai in New York City say they've developed a new artificial intelligence model designed for electrocardiogram analysis. The innovative AI approach could vastly improve the ...
Patient being positioned for MR study of the head and abdomen. — Image by Ptrump16. CC BY-SA 4.0 The company TeraRecon, who develop medical imaging advanced visualization, clinical AI, and workflow ...
Please provide your email address to receive an email when new articles are posted on . A deep learning algorithm applied to preoperative ECGs improved mortality risk prediction. The algorithm ran ...
This article is authored by Monika Shashank and Dr Md Ehtesham.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results